Identification of a Promoter for the Latent Membrane Protein 1 Gene of Epstein-Barr Virus That Is Specifically Activated in Human Epithelial Cells
- 1 July 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 16 (7) , 829-837
- https://doi.org/10.1089/dna.1997.16.829
Abstract
Latent membrane protein 1 (LMP 1) is one of two Epstein-Barr virus (EBV)-encoded proteins that expressed in nasopharyngeal carcinoma (NPC) cells. Previous studies showed that a 3.5-kb transcript of the LMP 1 gene, in addition to the 2.8-kb transcript, was detected in a B95-8-EBV-containing, nude mice-passaged NPC tumor, C15. This indicated that a transcript was initiated from a region 5′ to the putative promoter, ED-LI. We have isolated an EBV variant from a NPC tissue, and this virus strain contained a more pathogenic LMP 1 gene. DNA sequence analysis of the 5′-upstream region showed distinct variations as compared to that of B95-8 strain. To test if the LMP 1 gene of the NPC strain also contained an upstream promoter, we generated a series of deletion plasmids encompassing positions -1,030 to +20 of the LMP 1 promoter and tested for their abilities to drive the expression of the reporter gene in human epithelial cell lines, C-33A and NPC-TW076. We found that the region between -643 and -496 contained a promoter activity that was approximately five-fold higher than the putative promoter, ED-L1. This region between -643 and -496 was designated as ED-L1E. C-33A cells containing the genomic clone pT7(E) or the clone that had deleted a 94-bp ED-LI sequence (Δ94) was used to determine the transcription initiation sites by RNase protection assay. Results showed that a transcription initiation site was located at nucleotide 170,099 ("A") of EBV genome. The transcript was expressed in NPC biopsies and in human primary normal epithelial cells transfected with pT7(E) and Δ94, respectively, as examined by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. Furthermore, the ED-L1E was not regulated by the EBV-encoded nuclear antigen 1-mediated transcriptional enhancer family of repeats (FR) in C-33A cells. Our results suggested that the ED-L1E was specifically activated in epithelial cells. The biological significance of the selective usage of the ED-LIE promoter was discussed.Keywords
This publication has 29 references indexed in Scilit:
- Identification of a Novel Promoter Located Within theBamHI Q Region of the Epstein-Barr Virus Genome for the EBNA 1 GeneDNA and Cell Biology, 1995
- Characterization of 5′-upstream sequence of the latent membrane protein 1 (LMP-1) gene of an Epstein-Barr virus identified in nasopharyngeal carcinoma tissuesVirus Research, 1995
- The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.Proceedings of the National Academy of Sciences, 1994
- Mediation of Epstein-Barr Virus EBNA2 Transactivation by Recombination Signal-Binding Protein J κScience, 1994
- Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.Proceedings of the National Academy of Sciences, 1990
- Characterization of two newly established EBV-containing lymphoblastoid cell lines from patients with myeloid leukemiasLeukemia Research, 1990
- Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective studyNature, 1978
- Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinomaInternational Journal of Cancer, 1976
- Nasopharyngeal carcinoma. X. Presence of Epstein‐Barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and KenyaInternational Journal of Cancer, 1975
- A new technique for the assay of infectivity of human adenovirus 5 DNAVirology, 1973